BioSpace News Archive

Cancer Immunotherapy Market Size to Hit USD 261.9 Bn by 2030

According to Nova one advisor, the global Cancer Immunotherapy market was valued at USD 82.10 billion in 2021 and it is expected to hit around USD 261.9 billion by 2030 with a CAGR of 13.11% during the forecast period 2022 to 2030.

September 29, 2022
·
9 min read
Biotech Beach

Fundamental Thermoelectric Technology Patent Granted to DTP Thermoelectrics

DTP Thermoelectrics has been awarded a patent that opens the door for solid-state deep cooling thermal management.

September 29, 2022
·
3 min read
Policy

Defence Therapeutics Is Granted Patents in Japan and Israel Expanding Its Novel ADC Platform Technology in the Fast Growing Antibody-Drug Conjugates Market

Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) (“Defence” or the “Company”), a Canadian biopharmaceuticals company primarily focussed on the development of novel immune-oncology vaccines and drug delivery technologies including Antibody Drug Conjugate (“ADC”), is pleased to announce that a notice of allowance has been issued by the Japan Patent Office for its Japanese patent application no. 2018-568469.

September 29, 2022
·
4 min read
Increase In Government Investments In Genomics Research & Development Is Expected To Drive Achromatopsia Treatment Market Growth By 2030 | Reports And Data

The latest market analysis report published by Reports and Data, titled ‘Global Achromatopsia Treatment Market – Forecast to 2030,’ thoroughly examines the Achromatopsia Treatment industry to provide essential data & information for the targeted readers

September 29, 2022
·
6 min read
Increasing Number Of Clinical Trials Ongoing To Avail New And Safe Treatment Options Is Expected To Drive Acute Gout Flare Treatment Market Growth By 2030 | Reports And Data

The latest market analysis report published by Reports and Data, titled ‘Global Acute Gout Flare Treatment Market – Forecast to 2030,’ thoroughly examines the Acute Gout Flare Treatment industry to provide essential data & information for the targeted readers.

September 29, 2022
·
6 min read
Rising General Public’s Awareness For Usage Of Synthetic Growth Hormone Therapy Is Expected To Drive Adult Onset Growth Hormone Deficiency (GHD) Treatment Market Growth By 2030 | Reports And Data

The latest market analysis report published by Reports and Data, titled ‘Global Adult Onset Growth Hormone Deficiency (GHD) Treatment Market – Forecast to 2030,’ thoroughly examines the Adult Onset Growth Hormone Deficiency (GHD) Treatment industry to provide essential data & information for the targeted readers.

September 29, 2022
·
6 min read
Increasing Prevalence Of Genetic Disorders And Advancement In Healthcare Technologies And Treatments Are Majors Factors Driving Alpha Thalassemia Market Revenue Growth By 2030 | Reports and Data

The latest market analysis report published by Reports and Data, titled ‘Global Alpha Thalassemia Market – Forecast to 2030,’ thoroughly examines the Alpha Thalassemia industry to provide essential data & information for the targeted readers.

September 29, 2022
·
6 min read
Biotech Beach

City of Hope to Accelerate Immunotherapy Research and Treatment Innovation With $15 Million Gift From Ted Schwartz Family

City of Hope announced a $15 million gift from City of Hope patient and cancer survivor Ted Schwartz that will be used entirely to further accelerate immunotherapy research and treatment innovations, such as the chimeric antigen receptor T cell therapy that saved his life.

September 29, 2022
·
6 min read
Increasing Number Of Clinical Trials Ongoing To Avail Newer And Safer Treatment Options Is Expected To Drive Bronchial Spasm Treatment Market Growth By 2030 | Reports And Data

The latest market analysis report published by Reports and Data, titled ‘Global Bronchial Spasm Treatment Market – Forecast to 2030,’ thoroughly examines the Bronchial Spasm Treatment industry to provide essential data & information for the targeted readers.

September 29, 2022
·
6 min read
Drug Development

Preclinical Evaluation of Tricol Biomedical’s Absorbable Biocompatible Chitosan (ABC) Wound Dressing Demonstrates Bioabsorption and Biocompatability in Internal Bleeding

A preclinical study presented at the Military Health System Research Symposium this month demonstrated that the proprietary† Absorbable Biocompatible Chitosan investigational product from Tricol Biomedical is both absorbable and biocompatible in an internal bleeding rodent model.

September 29, 2022
·
3 min read